Business Description
Meta Health Ltd
ISIN : SG1O81915033
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.56 | |||||
Equity-to-Asset | -0.22 | |||||
Debt-to-Equity | -4.48 | |||||
Debt-to-EBITDA | -2.58 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -5.2 | |||||
Beneish M-Score | -7.89 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -53.6 | |||||
3-Year EPS without NRI Growth Rate | -48.1 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 38.27 | |||||
9-Day RSI | 36.12 | |||||
14-Day RSI | 36.04 | |||||
6-1 Month Momentum % | -11.11 | |||||
12-1 Month Momentum % | -11.11 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.87 | |||||
Quick Ratio | 0.87 | |||||
Cash Ratio | 0.5 | |||||
Days Inventory | 366.43 | |||||
Days Sales Outstanding | 719.57 | |||||
Days Payable | 723.94 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -31 | |||||
Shareholder Yield % | 67.19 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 30.86 | |||||
Operating Margin % | -146.86 | |||||
Net Margin % | -438.56 | |||||
FCF Margin % | -182.92 | |||||
ROE % | -1475.02 | |||||
ROA % | -63.52 | |||||
ROIC % | -29.23 | |||||
ROC (Joel Greenblatt) % | -59.6 | |||||
ROCE % | -84.2 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 3.5 | |||||
EV-to-EBIT | -5.29 | |||||
EV-to-EBITDA | -8.26 | |||||
EV-to-Revenue | 5.82 | |||||
EV-to-FCF | -3.18 | |||||
Earnings Yield (Greenblatt) % | -18.9 | |||||
FCF Yield % | -37.54 | |||||
Forward Rate of Return (Yacktman) % | 64.98 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Meta Health Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil S$) | 1.481 | ||
EPS (TTM) (S$) | -0.01 | ||
Beta | 0.55 | ||
Volatility % | 46.42 | ||
14-Day RSI | 36.04 | ||
14-Day ATR (S$) | 0.000306 | ||
20-Day SMA (S$) | 0.00725 | ||
12-1 Month Momentum % | -11.11 | ||
52-Week Range (S$) | 0.006 - 0.012 | ||
Shares Outstanding (Mil) | 1,030.85 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Meta Health Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Meta Health Ltd Stock Events
Event | Date | Price(S$) | ||
---|---|---|---|---|
No Event Data |
Meta Health Ltd Frequently Asked Questions
What is Meta Health Ltd(SGX:5DX)'s stock price today?
When is next earnings date of Meta Health Ltd(SGX:5DX)?
Does Meta Health Ltd(SGX:5DX) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |